Indeed, our results from multiple PCa cell lines support the role of TR4 in regulating DTX sensitivity, and adding Bex can enhance the DTX sensitivity, thus could be potentially used in those patients either not responsive or resistant to DTX. This evidence concerns the gene NR2C2 and posterior cortical atrophy.